@Normal= @00.00 Info ingnore= @00.10 Info MSnumber= @00.17 Info monthprint= @00.13 Info acceptmonth= @00.18 Info yearprint= @00.11 Info volume= @00.12 Info issue= @00.19 Info article type= @09.99 Text weblink= @Normal=[S"","Normal"]<*L*h"Standard"*kn0*kt0*ra0*rb0*d0*p(0,0,0,0,0,0,g,"U.S. English")Ps100t0h100z10k0b0cKf"Arial"> @00-Information=[S"","00-Information"]<*L*h"Standard"*kn0*kt0*ra0*rb0*d0*p(0,0,0,11,0,0,g,"U.S. English")PHs100t0h100z8k0b0cKf"Goudy"> @01-Article Head Deck 1=[S"","01-Article Head Deck 1"]<*L*h"Ragged & Heads"*kn0*ktA*ra0*rb0*d0*p(0,0,0,14,12,0,g,"U.S. English")*t(18,0,"1 "30,0,"1 ")Ps100t0h100z12k0b0c"LM0401"f"HelveticaNeue-Black"> @09-Body Text=[S"Normal","09-Body Text"]<*h"LM Body"*kt(2,2)*p(0,18,0,12,0,0,G,"U.S. English")Ps100t-2h100z10k0b0cKf"Times-Roman"> @00-Information:<@00.00 Info ingnore>MS# <@00.10 Info MSnumber>1000681<@00.00 Info ingnore> LabMed <@00.17 Info monthprint>Jun<@00.13 Info acceptmonth> <@00.18 Info yearprint>2002<@00.00 Info ingnore>;<@00.11 Info volume>33<@00.00 Info ingnore>(<@00.12 Info issue>7<@00.00 Info ingnore>) <@00.19 Info article type>news<@00.00 Info ingnore> @01-Article Head Deck 1:FDA Asks for Comment on Free Speech VS Drug Advertising Issues @09-Body Text:The Federal Register (May 16, 2002) carried a request from the Food and Drug Administration for public comment regarding regulations, policies, guidances and practices surrounding First Amendment case law as it affects advertising restrictions on pharmaceutical products. Some of the questions that the public is encouraged to answer are the arguments for regulating speech about drugs more comprehensively than about, for instance, dietary supplements. The request is also directed to whether promotional speech about drugs is inherently misleading unless it complies with FDA requirements. The inquiry questions whether decisions about advertising should turn on whether the information is given to "learned intermediaries" or to consumers. Access to the request in the Federal Register is via www.wais.access.gpo.gov, pages 34942-34944, Docket No. 02N-0209. Electronic comments can be submitted to http://<@09.99 Text weblink>www.fda.gov/dockets/ecomments<@$p> by July 30,2002.